Loading clinical trials...
Loading clinical trials...
This clinical study is being conducted at multiple sites to determine the activity, safety and tolerability of XL784 when given daily to patients with albuminuria due to diabetic nephropathy. XL784 is...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Symphony Evolution, Inc.
NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more
NCT04916132 · Chronic Kidney Diseases, Albuminuria, and more
NCT06843304 · Diabetic Nephropathy, T2DM
NCT01802034 · Kidney Diseases, Kidney Failure, Chronic, and more
NCT06833541 · Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM), and more
Parkway Medical Center
Birmingham, Alabama
Winston Technology, Inc.
Haleyville, Alabama
Redpoint Research
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions